Literature DB >> 24682975

Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs.

Amie C O'Donoghue1, Helen W Sullivan, Kathryn J Aikin.   

Abstract

BACKGROUND: Research suggests that quantitative information in direct-to-consumer (DTC) prescription drug ads may be helpful for consumers.
PURPOSE: The objective was to examine the effect of adding placebo rates and framing to DTC ads.
METHODS: In study 1, 2,000 Internet panel members with chronic pain participated in a randomized controlled experiment of DTC ads varying in placebo rate and framing. In study 2, 596 physicians ranked DTC ads varying in placebo rate and framing by how well they conveyed scientific information and their usefulness for patients.
RESULTS: In study 1, participants who viewed placebo rates were able to recall them and use them to form certain perceptions. A mixed frame led to lower placebo rate recall and perceived efficacy. In study 2, overall, physicians preferred a placebo/single frame ad.
CONCLUSIONS: Adding placebo rates to DTC ads may be useful for consumers. The evidence does not support using a mixed frame.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24682975      PMCID: PMC7370304          DOI: 10.1007/s12160-014-9603-1

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  16 in total

1.  Framing effects in choices between multioutcome life-expectancy lotteries.

Authors:  L M Bernstein; G B Chapman; A S Elstein
Journal:  Med Decis Making       Date:  1999 Jul-Sep       Impact factor: 2.583

Review 2.  Numeric, verbal, and visual formats of conveying health risks: suggested best practices and future recommendations.

Authors:  Isaac M Lipkus
Journal:  Med Decis Making       Date:  2007-09-14       Impact factor: 2.583

Review 3.  Risk communication in clinical practice: putting cancer in context.

Authors:  L M Schwartz; S Woloshin; H G Welch
Journal:  J Natl Cancer Inst Monogr       Date:  1999

4.  General performance on a numeracy scale among highly educated samples.

Authors:  I M Lipkus; G Samsa; B K Rimer
Journal:  Med Decis Making       Date:  2001 Jan-Feb       Impact factor: 2.583

5.  Effects of framing and level of probability on patients' preferences for cancer chemotherapy.

Authors:  A M O'Connor
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

6.  The framing of decisions and the psychology of choice.

Authors:  A Tversky; D Kahneman
Journal:  Science       Date:  1981-01-30       Impact factor: 47.728

7.  The role of numeracy in understanding the benefit of screening mammography.

Authors:  L M Schwartz; S Woloshin; W C Black; H G Welch
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

8.  "Hello, hello--it's English I speak!": a qualitative exploration of patients' understanding of the science of clinical trials.

Authors:  M Stead; D Eadie; D Gordon; K Angus
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

Review 9.  Clinical implications of numeracy: theory and practice.

Authors:  Wendy Nelson; Valerie F Reyna; Angela Fagerlin; Isaac Lipkus; Ellen Peters
Journal:  Ann Behav Med       Date:  2008-08-02

10.  Using a drug facts box to communicate drug benefits and harms: two randomized trials.

Authors:  Lisa M Schwartz; Steven Woloshin; H Gilbert Welch
Journal:  Ann Intern Med       Date:  2009-02-16       Impact factor: 25.391

View more
  7 in total

1.  Reporting quality of sham needles used as controls in acupuncture trials: a methodological evaluation.

Authors:  Ye-Seul Lee; Song-Yi Kim; Mariah Kim; Minseo Kim; Jiyoon Won; Hyangsook Lee; Myeong Soo Lee; Younbyoung Chae
Journal:  Chin Med       Date:  2022-05-31       Impact factor: 4.546

2.  Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.

Authors:  Pamela A Williams; Amie C O'Donoghue; Helen W Sullivan; Jessica Fitts Willoughby; Claudia Squire; Sarah Parvanta; Kevin R Betts
Journal:  Patient Educ Couns       Date:  2015-11-05

3.  Evaluation of adverse drug reaction formatting in drug information mobile phone applications.

Authors:  Sean M McConachie; Dena Berri; Jewel Konja; Christopher A Giuliano
Journal:  J Med Libr Assoc       Date:  2022-01-01

4.  Understanding adverse drug reactions in package leaflets - an exploratory survey among health care professionals.

Authors:  Viktoria Mühlbauer; Ingrid Mühlhauser
Journal:  BMC Health Serv Res       Date:  2015-11-10       Impact factor: 2.655

5.  Adverse drug reactions in drug information databases: does presentation affect interpretation?

Authors:  Sean M McConachie; Christopher A Giuliano; Insaf Mohammad; Pramodini B Kale-Pradhan
Journal:  J Med Libr Assoc       Date:  2020-01-01

6.  Evaluation of adverse drug reaction formatting in drug information databases.

Authors:  Sean M McConachie; Derek Volgyi; Hannah Moore; Christopher A Giuliano
Journal:  J Med Libr Assoc       Date:  2020-10-01

7.  The FDA's Diverse and Dynamic Activities in the Social and Behavioral Sciences: Advancing and Supporting Health Equity.

Authors:  Christine Lee; Melanie J McLean; Caroline J Huang; Anh Nguyen Zarndt; Kathryn J Aikin; Paula Rausch; Barbara R Cohen; Janine Delahanty; Danielle M Sholly; Wendy I Slavit; Ewa D Carlton
Journal:  J Prim Care Community Health       Date:  2021 Jan-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.